实用医学杂志 ›› 2021, Vol. 37 ›› Issue (20): 2614-2618.doi: 10.3969/j.issn.1006⁃5725.2021.20.009

• 临床研究 • 上一篇    下一篇

单囊型成釉细胞瘤根治性治疗和保守性治疗有效性及安全性的Meta分析

李乐1 刘亚男2 张俊1 孙远1 谢彤1 黄洁1 杨均平1   

  1. 1 清华大学医院口腔科(北京 100084);2 首都医科大学康复医学院/中国康复研究中心/北京博爱医院口腔科(北京 100068)

  • 出版日期:2021-10-25 发布日期:2021-10-25
  • 通讯作者: LIU Yanan E⁃mail:lyndentist@163.com
  • 基金资助:
    河北省医学科学研究重点课题(编号:20181158);清华大学医院科学研究基金(编号:110200019)

A meta⁃analysis on the efficacy and safety of radical and conservative therapy for unicysticameloblastoma

LI Le*LIU Ya′nanZHANG JunSUN YuanXIE TongHUANG JieYANG Junping.   

  1. Department of Stomatolo⁃ gy,Tsinghua University Hospital,Beijing 100084,China

  • Online:2021-10-25 Published:2021-10-25
  • Contact: 刘亚男 E⁃mail:lyndentist@163.com

摘要:

目的 系统评价单囊型成釉细胞瘤根治性和保守性治疗后的疗效。方法 计算机检索 PubMed、EMbase、Cochrane Central 数据库、CBM,检索有关单囊型成釉细胞瘤治疗的相关研究,检索时间 从建库至 2021 8 月。筛选文献/提取资料后,采用 RevMan5.4 软件进行 Meta 分析。结果 按检索策略 检索中英文文章,共检索出 772 篇文章,其中 11 篇研究最终符合入选标准,共计 485 例单囊型成釉细胞 瘤患者接受了根治性或保守性治疗。其中接受根治性手术的患者 126 例,接受保守性治疗的患者 359 例。根治性治疗后的复发率为 3.17%,而保守性治疗后其复发率为 19.22%,根治性手术的复发率更低 OR = 0.24,95%CI:0.11 ~ 0.52,P = 0.000 3)。但根治性手术围手术期出血量较高(MD = 167.12,95% CI:140.80 ~ 193.44,P < 0.001),手 长(MD = 158.77,95%CI:96.48 ~ 221.06,P < 0.001)。结论 该研究表明单囊型成釉细胞瘤虽然是良性肿瘤,但仍可能复发,不同的治疗策略在复发率上有明显差异,保守性治疗与根治性治疗相比更易复发,但在手术的安全性方面,保守手 术更安全。

关键词:

成釉细胞瘤, 单囊型成釉细胞瘤, 复发, 围手术期出血, 手术时间, Meta 分析

Abstract:

Objective To explore the efficacy of radical and conservative therapies for unicysticameloblas⁃ toma systematically. Methods The relevant studies on therapies for unicysticameloblastoma,which had published from the establishment of the databases to August 2021,were searched in PubMed,EMbase,CENTRAL and CBM. After screening the literatures and extracting the data,we performed a meta ⁃analysis by using RevMan5.4 software. Results According to the search strategies for searching articles in Chinese or English,72 articles were determined,11 of which met the inclusion criteria. A total of 485 patients with unicysticameloblastomas received either radical or conservative treatment,126 of whom underwent radical surgery and the rest 359 received conserva⁃ tive treatment. The recurrence rate was 3.17% for radical surgery and 19.22% for conservative treatment. The meta⁃ analysis showed a lower risk of recurrence of unicysticameloblastomas in radical treatment than in conservative treat⁃ ment(OR = 0.24,95%CI:0.11 ~ 0.52,P = 0.000 3),but perioperative blood loss was greater(MD = 167.12 95%CI:140.80 ~ 193.44,P < 0.001)and surgical duration was longer(MD = 158.77,95%CI:96.48 ~ 221.06 P < 0.001)in radical treatment. Conclusions This study shows that although unicysticameloblastoma is a benign tumor,it′ s still very likely to recur. Different treatment strategies have significant statistical differences in recur⁃ rence rates. Conservative treatment is more prone to recurrence than radical treatment,whereas it is safer.

Key words:

ameloblastoma, unicysticameloblastoma, recurrence, perioperative blood loss, surgi? cal duration, meta analysis

中图分类号: